[Carcinogenic effect of DMBA in rats via transplacental exposure].
D000818:Animals; D001551:Benz(a)Anthracenes / Q000494:pharmacology*; D001932:Brain Neoplasms / Q000139:chemically induced; D002273:Carcinogens / Q000494:pharmacology*; D004622:Embryo, Mammalian / Q000187:drug effects; D005260:Female; D006391:Hemangioma / Q000139:chemically induced; D007275:Injections, Intravenous; D007414:Intestinal Neoplasms / Q000139:chemically induced; D007583:Jejunum; D007680:Kidney Neoplasms / Q000139:chemically induced; D008431:Maternal-Fetal Exchange / Q000187:drug effects*; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced; D009380:Neoplasms, Nerve Tissue / Q000139:chemically induced; D010051:Ovarian Neoplasms / Q000139:chemically induced; D011247:Pregnancy; D051381:Rats; D013120:Spinal Cord Neoplasms / Q000139:chemically induced; D013997:Time Factors
D001551:Benz(a)Anthracenes; D002273:Carcinogens
Kantserogennyĭ éffekt DMBA u krys pri transplatsentarnom vozdeĭstvii